Jan 21, 2025, 14:12
Pashtoon Kasi about targeting BRAFV600E in Colorectal Cancer
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, posted on X:
“BRAFV600E is present in about 10% of patients with Colorectal Cancer.
Important to recognize since treatment and strategies might differ. Two trials have shown the addition of immunotherapy to the targeted therapies as promising.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 21, 2025, 14:12
Jan 21, 2025, 14:12
Jan 21, 2025, 14:07
Jan 21, 2025, 14:00
Jan 21, 2025, 13:59
Jan 21, 2025, 13:33
Jan 21, 2025, 13:07
Jan 21, 2025, 13:06